文献速递妇科生殖医学

结直肠子宫内膜异位症药物治疗还是手术?共同决策模式的结果

Medical treatment or surgery for colorectal endometriosis? Results of a shared decision-making approach.
PubMed 文献 · Hum Reprod · 2018-01-01

该平行队列研究纳入87例有手术指征的症状性结直肠子宫内膜异位症女性,采用标准化共同决策流程让患者选择治疗。50例选择药物(低剂量口服避孕药12例或孕激素38例),37例选择手术;两组治疗满意度均较高,调整OR无显著差异,但药物组在腹泻、痛经、非经期盆腔痛及SF-12躯体评分方面更优。

要点

  • 87例有手术指征的结直肠子宫内膜异位症女性经共同决策后,50例选择药物,37例选择手术。
  • 12个月随访时药物组满意39例(78%),手术组满意28例(76%),调整OR 1.37(95%CI 0.45-4.15)。
  • 手术组发生7例主要并发症(19%);药物组6例因无效或不耐受转手术。

核心结论

  • 经充分告知并赋权的共同决策后,大多数已有手术指征的非梗阻性结直肠子宫内膜异位症患者偏好药物治疗。
  • 允许患者选择偏好治疗可能最大化干预措施的潜在效果。

研究设计与样本

  • 平行队列研究,纳入87例转诊至本中心且有结直肠子宫内膜异位症手术指征的女性。
  • 采用标准化共同决策流程,允许女性选择偏好治疗。
  • 药物治疗组中位随访40[18-60]个月,手术组45[30-67]个月。

主要发现

  • 药物治疗组6例因药物无效(3例)或不耐受(3例)要求手术。
  • 手术组发生7例主要并发症(19%)。
  • 12个月随访时药物组39例(78%)满意,手术组28例(76%)满意(调整OR 1.37;95%CI 0.45-4.15;意向性分析)。
  • 最终随访时药物组满意72%,手术组65%(调整OR 1.74;95%CI 0.62-4.85)。
  • 60个月无不满意累积比例药物组71% vs 手术组61%(P=0.61);风险发生率比1.21(95%CI 0.57-2.62)。

临床怎么用

  • 作者认为,通过共同决策充分告知并赋权后,大多数非梗阻性结直肠子宫内膜异位症患者可能偏好药物治疗。
  • 原文未据此给出具体临床推荐。

局限性

  • 治疗非随机分配,可能存在选择偏倚和混杂。
  • 样本量小,存在II类错误风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the degree of patient satisfaction in women with symptomatic colorectal endometriosis who choose medical or surgical treatment after a shared decision-making (SDM) process? SUMMARY ANSWER: The degree of satisfaction with treatment was high both in women who chose medical treatment with a low-dose oral contraceptive (OCP) or a progestin, and in those who chose to undergo surgical resection of bowel endometriosis. WHAT IS KNOWN ALREADY: Hormonal therapies and surgery for colorectal endometriosis have been investigated in non-comparative studies with inconsistent results. STUDY DESIGN, SIZE, DURATION: Parallel cohort study conducted on 87 women referring to our centre with an indication to surgery for colorectal endometriosis. A standardised SDM process was adopted, allowing women to choose their preferred treatment. Median follow-up was 40 [18-60] months in the medical therapy group and 45 [30-67] in the surgery group. PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients with endometriosis infiltrating the proximal rectum, the rectosigmoid junction, and the sigmoid, not causing severe sub-occlusive symptoms were enroled. A total of 50 patients chose treatment with an OCP (n = 12) or a progestin (n = 38), whereas 37 women confirmed their previous indication to surgery. Patient satisfaction was graded according to a 5-category scale. Variations in bowel and pain symptoms were measured by means of a 0-10 numeric rating scale. Constipation was assessed with the Knowles-Eccersley-Scott Symptom Questionnaire (KESS), health-related quality of life with the Short Form-12 questionnaire (SF-12), psychological status with the Hospital Anxiety and Depression scale (HADS) and sexual functioning with the Female Sexual Function Index (FSFI). MAIN RESULTS AND THE ROLE OF CHANCE: Six women in the medical therapy group requested surgery because of drug inefficacy (n = 3) or intolerance (n = 3). Seven major complications were observed in the surgery group (19%). At 12-month follow-up, 39 (78%) women in the medical therapy group were satisfied with their treatment, compared with 28 (76%) in the surgery group (adjusted odds ratio (OR), 1.37; 95% confidence interval (CI), 0.45-4.15; intention-to-treat analysis). Corresponding figures at final follow-up assessment were 72% in the former group and 65% in the latter one (adjusted OR, 1.74; 95% CI, 0.62-4.85). The 60-month cumulative proportion of dissatisfaction-free participants was 71% in the medical therapy group compared with 61% in the surgery group (P = 0.61); the Hazard incidence rate ratio was 1.21 (95% CI, 0.57-2.62). Intestinal complaints were ameliorated by both treatments. Significant between-group differences in favour of medical treatment were observed at 12-month follow-up in diarrhoea, dysmenorrhoea, non-menstrual pelvic pain and SF-12 physical component scores. The total HADS score improved significantly in both groups, whereas the total FSFI score improved only in women who chose medical therapy. LIMITATIONS REASONS FOR CAUTION: As treatments were not randomly assigned, selection bias and confounding are likely. The small sample size exposes to the risk of type II errors. WIDER IMPLICATIONS OF THE FINDINGS: When adequately informed and empowered through a SDM process, most patients with non-occlusive colorectal endometriosis who had already received a surgical indication, preferred medical therapy. The possibility of choosing the preferred treatment may allow maximisation of the potential effect of the interventions. STUDY FUNDING/COMPETING INTEREST(S): This study was financed by Italian fiscal contribution '5 × 1000'-Ministero dell'Istruzione, dell'Università e della Ricerca-devolved to Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy. P.V., M.P.F., R.R., D.D., A.R., P.M., O.D.G. and M.C. declare that they have no conflicts of interest. E.S. received grants from Ferring and Serono.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Vercellini P, Frattaruolo MP, Rosati R, et al. Medical treatment or surgery for colorectal endometriosis? Results of a shared decision-making approach. Hum Reprod. 2018. PMID: 29228373. doi:10.1093/humrep/dex364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。